An announcement from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available.
ResMed Inc has announced a decrease in the total number of CHESS Depositary Interests (CDIs) issued over quoted securities, with a net reduction of 2,878,870 CDIs from the previous month. This change is attributed to net transfers between CDIs and common stock as quoted on the NYSE. Additionally, there has been an increase in the total number of securities over which CDIs have not been issued, due to transfers, new share issues related to stock options, and share repurchases on the NYSE. These adjustments reflect the company’s ongoing management of its securities and stock plans.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc is a company operating in the healthcare industry, primarily focusing on the development and manufacturing of equipment related to sleep disorders and respiratory care. The company is known for its innovative solutions in sleep apnea treatment and other respiratory conditions, serving a global market.
YTD Price Performance: -3.90%
Average Trading Volume: 1,139,172
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$52.03B
See more insights into RMD stock on TipRanks’ Stock Analysis page.